
This new landmark project is forecast to ultimately generate estimated annual gross revenues of $500 million for the partnership Callan JMB is entitled to receive a 21% participation in the venture, which could represent approximately $105 million in revenue for the first year and over $400 million in revenues over the five-year agreement The next phase of the project is being initiated with the development of the Marion 9 Biomanufacturing Center at the Atlas Complex by Callan JMB in Marion, Alabama MARION, Ala., July 29, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced breaking ground at the Atlas Complex representing the completion of an important strategic partnership with Alabama State University (“ASU”) to support the development of a significant integrated pharmaceutical manufacturing ecosystem designed to strengthen the United States (U.S.) domestic pharmaceutical production, enhance U.S. supply chain resilience, and improve national medical preparedness.






